ENDRA Life Sciences Inc.
NDRA· Nasdaq
NDRAENDRA Life Sciences Inc.
Filed Nov 14, 2017 · 10-Q · 45 days after period end · 0001654954-17-010633
| Metric | Q3 2017 | Q3 2016 |
|---|---|---|
| Revenue | $287.00K | $0.00 |
| Net Income | -$908.91K | -$977.90K |
| EPS Diluted | -$0.23 | -$1.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ENDRA Life Sciences Inc. · CIK 1681682 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 14, 2017 · 45 d after period end
